Cargando…

Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study

PURPOSE: Low-dose computed tomography (LDCT) of the chest is a recommended diagnostic tool in early stage of COVID-19 pneumonia. High age, several comorbidities as well as poor physical fitness can negatively influence the outcome within COVID-19 infection. We investigated whether the ratio of fat t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kottlors, Jonathan, Zopfs, David, Fervers, Philipp, Bremm, Johannes, Abdullayev, Nuran, Maintz, David, Tritt, Stephanie, Persigehl, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480673/
https://www.ncbi.nlm.nih.gov/pubmed/32961451
http://dx.doi.org/10.1016/j.ejrad.2020.109274
_version_ 1783580456104493056
author Kottlors, Jonathan
Zopfs, David
Fervers, Philipp
Bremm, Johannes
Abdullayev, Nuran
Maintz, David
Tritt, Stephanie
Persigehl, Thorsten
author_facet Kottlors, Jonathan
Zopfs, David
Fervers, Philipp
Bremm, Johannes
Abdullayev, Nuran
Maintz, David
Tritt, Stephanie
Persigehl, Thorsten
author_sort Kottlors, Jonathan
collection PubMed
description PURPOSE: Low-dose computed tomography (LDCT) of the chest is a recommended diagnostic tool in early stage of COVID-19 pneumonia. High age, several comorbidities as well as poor physical fitness can negatively influence the outcome within COVID-19 infection. We investigated whether the ratio of fat to muscle area, measured in initial LDCT, can predict severe progression of COVID-19 in the follow-up period. METHOD: We analyzed 58 individuals with confirmed COVID-19 infection that underwent an initial LDCT in one of two included centers due to COVID-19 infection. Using the ratio of waist circumference per paravertebral muscle circumference (FMR), the body composition was estimated. Patient outcomes were rated on an ordinal scale with higher numbers representing more severe progression or disease associated complications (hospitalization/ intensive care unit (ICU)/ tracheal intubation/ death) within a follow-up period of 22 days after initial LDCT. RESULTS: In the initial LDCT a significantly higher FMR was found in patients requiring intensive care treatment within the follow-up period. In multivariate logistic regression analysis, FMR (p < .001) in addition to age (p < .01), was found to be a significant predictor of the necessity for ICU treatment of COVID-19 patients. CONCLUSION: FMR as potential surrogate of body composition and obesity can be easily determined in initial LDCT of COVID-19 patients. Within the multivariate analysis, in addition to patient age, low muscle area in proportion to high fat area represents an additional prognostic information for the patient outcome and the need of an ICU treatment during the follow-up period within the next 22 days. This multicentric pilot study presents a method using an initial LDCT to screen opportunistically for obese patients who have an increased risk for the need of ICU treatment. While clinical capacities, such as ICU beds and ventilators, are more crucial than ever to help manage the current global corona pandemic, this work introduces an approach that can be used for a cost-effective way to help determine the amount of these rare clinical resources required in the near future.
format Online
Article
Text
id pubmed-7480673
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-74806732020-09-09 Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study Kottlors, Jonathan Zopfs, David Fervers, Philipp Bremm, Johannes Abdullayev, Nuran Maintz, David Tritt, Stephanie Persigehl, Thorsten Eur J Radiol Research Article PURPOSE: Low-dose computed tomography (LDCT) of the chest is a recommended diagnostic tool in early stage of COVID-19 pneumonia. High age, several comorbidities as well as poor physical fitness can negatively influence the outcome within COVID-19 infection. We investigated whether the ratio of fat to muscle area, measured in initial LDCT, can predict severe progression of COVID-19 in the follow-up period. METHOD: We analyzed 58 individuals with confirmed COVID-19 infection that underwent an initial LDCT in one of two included centers due to COVID-19 infection. Using the ratio of waist circumference per paravertebral muscle circumference (FMR), the body composition was estimated. Patient outcomes were rated on an ordinal scale with higher numbers representing more severe progression or disease associated complications (hospitalization/ intensive care unit (ICU)/ tracheal intubation/ death) within a follow-up period of 22 days after initial LDCT. RESULTS: In the initial LDCT a significantly higher FMR was found in patients requiring intensive care treatment within the follow-up period. In multivariate logistic regression analysis, FMR (p < .001) in addition to age (p < .01), was found to be a significant predictor of the necessity for ICU treatment of COVID-19 patients. CONCLUSION: FMR as potential surrogate of body composition and obesity can be easily determined in initial LDCT of COVID-19 patients. Within the multivariate analysis, in addition to patient age, low muscle area in proportion to high fat area represents an additional prognostic information for the patient outcome and the need of an ICU treatment during the follow-up period within the next 22 days. This multicentric pilot study presents a method using an initial LDCT to screen opportunistically for obese patients who have an increased risk for the need of ICU treatment. While clinical capacities, such as ICU beds and ventilators, are more crucial than ever to help manage the current global corona pandemic, this work introduces an approach that can be used for a cost-effective way to help determine the amount of these rare clinical resources required in the near future. Elsevier B.V. 2020-11 2020-09-09 /pmc/articles/PMC7480673/ /pubmed/32961451 http://dx.doi.org/10.1016/j.ejrad.2020.109274 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Article
Kottlors, Jonathan
Zopfs, David
Fervers, Philipp
Bremm, Johannes
Abdullayev, Nuran
Maintz, David
Tritt, Stephanie
Persigehl, Thorsten
Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study
title Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study
title_full Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study
title_fullStr Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study
title_full_unstemmed Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study
title_short Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study
title_sort body composition on low dose chest ct is a significant predictor of poor clinical outcome in covid-19 disease - a multicenter feasibility study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480673/
https://www.ncbi.nlm.nih.gov/pubmed/32961451
http://dx.doi.org/10.1016/j.ejrad.2020.109274
work_keys_str_mv AT kottlorsjonathan bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy
AT zopfsdavid bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy
AT ferversphilipp bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy
AT bremmjohannes bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy
AT abdullayevnuran bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy
AT maintzdavid bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy
AT trittstephanie bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy
AT persigehlthorsten bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy